1. The Joint Commission . Preventing Central Line–Associated Bloodstream Infections: A Global Challenge, a Global Perspective. Oak Brook: Joint Commission Resources; 2012. [Google Scholar] Show 2. Pronovost P, Needham D, Berenholtz S, Frank J, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732. doi: 10.1056/NEJMoa061115. [PubMed] [CrossRef] [Google Scholar] 3. Datta P, Rani H, Chauhan R, Gombar S, Chander J. Health-care-associated infections: Risk factors and epidemiology from an intensive care unit in Northern India. Indian J Anaesth. 2014;58(1):30–35. doi: 10.4103/0019-5049.126785. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 4. Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med. 2006;34(3):668–675. doi: 10.1097/01.CCM.0000201404.05523.34. [PubMed] [CrossRef] [Google Scholar] 5. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int. 2006;69(1):161–164. doi: 10.1038/sj.ki.5000012. [PubMed] [CrossRef] [Google Scholar] 6. Richards B, Chaboyer W, Bladen T, Schluter PJ. Effect of central venous catheter type on infections: a prospective clinical trial. J Hosp Infect. 2003;54(1):10–17. doi: 10.1016/S0195-6701(03)00071-9. [PubMed] [CrossRef] [Google Scholar] 7. Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis. 2000;38(1):1–5. doi: 10.1016/S0732-8893(00)00166-8. [PubMed] [CrossRef] [Google Scholar] 8. Yoshida J, Ishimaru T, Fujimoto M, Hirata N, Matsubara N, Koyanagi N. Risk factors for central venous catheter-related bloodstream infection: a 1073-patient study. J Infect Chemother. 2008;14(6):399–403. doi: 10.1007/s10156-008-0637-9. [PubMed] [CrossRef] [Google Scholar] 9. Zhang P, Yuan J, Tan H, Lv R, Chen J. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif. 2009;27(2):206–211. doi: 10.1159/000197560. [PubMed] [CrossRef] [Google Scholar] 10. Apisarnthanarak A, Greene MT, Kennedy EH, Khawcharoenporn T, Krein S, Saint S. National survey of practices to prevent healthcare-associated infections in Thailand: the role of safety culture and collaboratives. Infect Control Hosp Epidemiol. 2012;33(7):711–717. doi: 10.1086/666330. [PubMed] [CrossRef] [Google Scholar] 11. Apisarnthanarak A, Khawcharoenporn T, Mundy LM. National survey of suboptimal and unnecessary practices for central line placement and management in Thailand. Am J Infect Control. 2013;41(2):e11–e13. doi: 10.1016/j.ajic.2012.07.019. [PubMed] [CrossRef] [Google Scholar] 12. Jaggi N, Sissodia P. Repeated multimodal supervision programs to reduce the central line-associated bloodstream infection rates in an Indian corporate hospital. Healthcare Infection. 2014;19:53–58. doi: 10.1071/HI13030. [CrossRef] [Google Scholar] 13. Jaggi N, Rodrigues C, Rosenthal VD, Todi SK, Shah S, Saini N, et al. Impact of an International Nosocomial Infection Control Consortium multidimensional approach on central line-associated bloodstream infection rates in adult intensive care units in eight cities in India. Int J Infect Dis. 2013;17(12):1218–1224. doi: 10.1016/j.ijid.2013.07.007. [PubMed] [CrossRef] [Google Scholar] 14. Jaggi N, Nirwan P, Naryana E, Kaur KP. The analysis and impact of three successive intervention programmes directed to reduce central line associated blood stream infections over a four year period in a tertiary care hospital in India. Antimicrobial Resistance and Infection Control. 2013;2(Suppl 1):2. doi: 10.1186/2047-2994-2-S1-P2. [CrossRef] [Google Scholar] 15. Parienti J, Mongardon N, Megarbane B, Mira J, Kalfon P, Gros A, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373:1220–1229. doi: 10.1056/NEJMoa1500964. [PubMed] [CrossRef] [Google Scholar] 16. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299:2413–2422. doi: 10.1001/jama.299.20.2413. [PubMed] [CrossRef] [Google Scholar] 17. Nagashima G, Kikuchi T, Tsuyuzaki H, et al. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother. 2006;12:363–365. doi: 10.1007/s10156-006-0471-X. [PubMed] [CrossRef] [Google Scholar] 18. Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327:361. doi: 10.1136/bmj.327.7411.361. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 19. Larson EL, Rackoff WR, Weiman M, et al. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control. 1995;23:251–269. doi: 10.1016/0196-6553(95)90070-5. [PubMed] [CrossRef] [Google Scholar] 20. WHO Guidelines on Hand Hygiene in Health Care: a Summary 2009. 21. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343. doi: 10.1016/0140-6736(91)90479-9. [PubMed] [CrossRef] [Google Scholar] 22. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792–801. doi: 10.7326/0003-4819-136-11-200206040-00007. [PubMed] [CrossRef] [Google Scholar] 23. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–238. doi: 10.2307/30145574. [PubMed] [CrossRef] [Google Scholar] 24. Lin TY, Lee CM, Wang FD, et al. Taiwan guidelines for prevention and control of intravascular catheter-related bloodstream infections. 2011. 25. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93. doi:10.1093/cid/cir257. [PMC free article] [PubMed] 27. Guide to the eliminations of catheter–related bloodstream infections- An APIC guide 2009. 28. Getting Started Kit: Prevent Central Line Infections, Central Line Associated - Blood Stream Infections (CLA-BSI) Safer Healthcare Now! Campaign (SHN) 2009 29. Central line insertion and maintenance guidelines. Australian Commission on Safety and Quality in Health care 2012. 30. Camp-Sorrell D, editor. Access Device Guidelines: Recommendations for Nursing Practice and Education. 3. Pittsburgh: Oncology Nursing Society; 2011. [Google Scholar] 31. Basic Infection Control And Prevention Plan for Outpatient Oncology Settings CDC December 2011 32. Guide to the Elimination of Infections in Hemodialysis, An APIC Guide 2010 33. NHMRC Australian Guidelines for the Prevention and Control of Infection in Healthcare. Commonwealth of Australia 2010. 36. Guide H-t. Prevent Central Line-Associated Bloodstream Infections. Cambridge: Institute for Healthcare Improvement; 2012. [Google Scholar] 37. Weaver SJ, Lubomksi LH, Wilson RF, Pfoh ER, Martinez KA, Dy SM. Promoting a culture of safety as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5 pt 2):369–374. doi: 10.7326/0003-4819-158-5-201303051-00002. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 38. Hatler CW, Mast D, Corderella J, et al. Using evidence and process improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. Am J Crit Care. 2006;15(6):549–555. [PubMed] [Google Scholar] 39. Warye KL, Murphy DM. Targeting zero health care–associated infections. Am J Infect Control. 2008;36:683–684. doi: 10.1016/j.ajic.2008.10.016. [PubMed] [CrossRef] [Google Scholar] 40. Gilbert GL, Cheung PY, Kerridge IB. Infection control, ethics and accountability. Med J Aust. 2009;190(12):696–698. [PubMed] [Google Scholar] 41. Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(7):753–771. doi: 10.1086/676533. [PubMed] [CrossRef] [Google Scholar] 42. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001;107(6):1431–1436. doi: 10.1542/peds.107.6.1431. [PubMed] [CrossRef] [Google Scholar] 43. Spencer C, Orr D, Hallam S, Tillmanns E. Daily bathing with octenidine on an intensive care unit is associated with a lower carriage rate of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2013;83(2):156–159. doi: 10.1016/j.jhin.2012.10.007. [PubMed] [CrossRef] [Google Scholar] 44. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, Herault MC, Haouache H, Calvino-Gunther S, Gestin B, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301:1231–1241. doi: 10.1001/jama.2009.376. [PubMed] [CrossRef] [Google Scholar] 45. Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol. 2010;31(8):846–849. doi: 10.1086/655017. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 46. Huang EY, Chen C, Abdullah F, et al. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2011;46(10):2000–2011. doi: 10.1016/j.jpedsurg.2011.06.017. [PubMed] [CrossRef] [Google Scholar] 47. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–e193. doi: 10.1093/cid/cir257. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 48. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis. 2010;50(2):210–217. doi: 10.1086/648717. [PubMed] [CrossRef] [Google Scholar] 49. Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2013;6:CD007878. [PubMed] [Google Scholar] 50. Hagau N, Studnicska D, Gavrus RL, Csipak G, Hagau R, Slavcovici AV. Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters. Eur J Anaesthesiol. 2009;26:752–758. doi: 10.1097/EJA.0b013e32832a3a84. [PubMed] [CrossRef] [Google Scholar] 51. Antonelli M, De Pascale G, Ranieri VM, Pelaia P, Tufano R, Piazza O, et al. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive(R)) vs conventional catheters in intensive care unit patients. J Hosp Infect. 2012;82:101–107. doi: 10.1016/j.jhin.2012.07.010. [PubMed] [CrossRef] [Google Scholar] 52. Weber JM, Sheridan RL, Fagan S, Ryan CM, Pasternack MS, Tompkins RG. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population. J Burn Care Res. 2012;33:539–543. doi: 10.1097/BCR.0b013e31823c4cd5. [PubMed] [CrossRef] [Google Scholar] 53. Chelliah A, Heydon KH, Zaoutis TE, Rettig SL, Dominguez TE, Lin R, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J. 2007;26:816–820. doi: 10.1097/INF.0b013e318123e8bf. [PubMed] [CrossRef] [Google Scholar] 54. Bertini G, Elia S, Ceciarini F, Dani C. Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system. Early Hum Dev. 2013;89:21–25. doi: 10.1016/j.earlhumdev.2012.07.003. [PubMed] [CrossRef] [Google Scholar] 55. Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, et al. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014;63:479–490. doi: 10.1053/j.ajkd.2013.08.016. [PubMed] [CrossRef] [Google Scholar] 56. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47:83–93. doi: 10.1086/588667. [PubMed] [CrossRef] [Google Scholar] 57. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008;51:233–241. doi: 10.1053/j.ajkd.2007.10.038. [PubMed] [CrossRef] [Google Scholar] 58. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant. 2008;23:1666–1672. doi: 10.1093/ndt/gfm847. [PubMed] [CrossRef] [Google Scholar] 59. Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75:1–11. doi: 10.1016/j.jhin.2009.12.017. [PubMed] [CrossRef] [Google Scholar] 60. Zacharioudakis IM, Zervou FN, Arvanitis M, Ziakas PD, Mermel LA, Mylonakis E. Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014. doi:10.1093/cid/ciu671. [PubMed] 61. van de Wetering MD, van Woensel JB, Lawrie TA. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane Database Syst Rev. 2013;11:CD003295. [PMC free article] [PubMed] [Google Scholar] 62. Catheter WM. Llubrication and fixation: interventions. Br J Nurs. 2013;22(10):566. doi: 10.12968/bjon.2013.22.10.566. [PubMed] [CrossRef] [Google Scholar] 63. Alekseyev S, Byrne M, Carpenter A, Franker C, Kidd C, Hulton L. Prolonging the life of a patient’s IV: an integrative review of intravenous securement devices. Medsurg Nurs. 2012;21(5):285–292. [PubMed] [Google Scholar] 64. Petree C, Wright DL, Sanders V, Killion JB. Reducing blood stream infections during catheter insertion. Radiol Technol. 2012;83(6):532–540. [PubMed] [Google Scholar] 65. Cotogni P, Pittiruti M, Barbero C, Monge T, Palmo A, Boggio Bertinet D. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. JPEN J Parenter Enteral Nutr. 2013;37(3):375–383. doi: 10.1177/0148607112460552. [PubMed] [CrossRef] [Google Scholar] 66. Christopher C, Maki DG. The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. Clin Infect Dis. 2002;34(10):1362–1368. doi: 10.1086/340105. [PubMed] [CrossRef] [Google Scholar] 67. Simonova G, Rickard CM, Dunster KR, Smyth DJ, McMillan D, Fraser JF. Cyanoacrylate tissue adhesives - effective securement technique for intravascular catheters: in vitro testing of safety and feasibility. Anaesth Intensive Care. 2012;40(3):460–466. [PubMed] [Google Scholar] 68. Egan GM, Siskin GP, Weinmann R, 4th, Galloway MM. A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system. J Infus Nurs. 2013;36(3):181–188. doi: 10.1097/NAN.0b013e3182893690. [PubMed] [CrossRef] [Google Scholar] 69. Sundararajan K, Wills S, Chacko B, Kanabar G, O’Connor S, Deane A. Impact of delirium and suture-less securement on accidental vascular catheter removal in the ICU. Anaesth Intensive Care. 2014;42(4):473–479. [PubMed] [Google Scholar] 70. Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis. 2007;44:1408–1414. doi: 10.1086/517538. [PubMed] [CrossRef] [Google Scholar] 71. Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol. 2006;27(1):67–70. doi: 10.1086/499166. [PubMed] [CrossRef] [Google Scholar] 72. Mazher MA, Kallen A, Edwards JR, Donlan RM. An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters. Lett Appl Microbiol. 2013;57(4):282–287. [PMC free article] [PubMed] [Google Scholar] 73. Pichler J, Soothill J, Hill S. Reduction of blood stream infections in children following a change to chlorhexidine disinfection of parenteral nutrition catheter connectors. Clin Nutr. 2014;33(1):85–89. doi: 10.1016/j.clnu.2013.03.021. [PubMed] [CrossRef] [Google Scholar] 74. Casey AL, Karpanen TJ, Nightingale P, Cook M, Elliott TS. Microbiological comparison of a silver-coated and a non-coated needleless intravascular connector in clinical use. J Hosp Infect. 2012;80(4):299–303. doi: 10.1016/j.jhin.2012.01.005. [PubMed] [CrossRef] [Google Scholar] 75. Menyhay SZ, Maki DG. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am J Infect Control. 2008;36(10):S174. [PubMed] [Google Scholar] 76. Sweet MA, Cumpston A, Briggs F, Craig M, Hamadani M. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control. 2012;40(10):931–934. doi: 10.1016/j.ajic.2012.01.025. [PubMed] [CrossRef] [Google Scholar] 77. Sandora TJ, Graham DA, Conway M, Dodson B, Potter-Bynoe G, Margossian SP. Impact of needleless connector change frequency on central line-associated bloodstream infection rate. Am J Infect Control. 2014;42(5):485–489. doi: 10.1016/j.ajic.2014.01.022. [PubMed] [CrossRef] [Google Scholar] 78. Ling ML, Apisarnthanarak A, Madriaga G. The burden of healthcare-associated infections in Southeast Asia: A systematic literature review and meta-analysis. Clinical Infectious Diseases 2015: civ095v1-civ095 [PubMed] Why is it important to use a transparent dressing to secure the IV cannula?The use of transparent film dressing for insertion of peripheral intravenous catheter can be recommended as it increases the dwell time for the catheter and reduces incidence of complications.
What type of dressing should be used for a peripheral IV site?Cover the cannula insertion site with sterile transparent semipermeable, occlusive dressing (e.g. Tegadermtm, IV 3000tm) placed using an aseptic non touch technique over the catheter. This will allow continuous observation of the site and to help stabilise and secure the catheter.
Do you use sterile technique for IV insertion?The gloves that accompany most IV insertion kits are clean gloves and not sterile. Remember once the skin is prepped, the site should not be touched again with a gloved or non-gloved hand, or the site will need to be cleansed again.
What should be used to clean the skin before IV line insertion?Skin decontamination
The skin should be decontaminated at the insertion site with 2% chlorhexidine gluconate in 70% alcohol and allowed to dry before inserting a vascular access device.
|
